Vaccine choices, regret and patient characteristics in covid-19 positive patients admitted as an inpatient: a prospective multicentre trial

None listed

Patient presents/referred to hospital, unvaccinated/vaccinated status is flagged SARS covid-19 infection is confirmed using standardised testing Patient is admitted as an inpatient in the RAH/FMC Approached for inclusion and participation by Dr Lin, on day 3 or whenever well enough. Inclusion and survey are completed either electronically or via a telephone system built into isolation bay. No face-to-face contact, no prolongation of in-person contact. No use of PPE or risk of additional exposure to staff. Microsoft Forms platform survey allowing for electronic signature for written informed consent, or if no electronic device available/other technical difficulty- patient gives verbal consent for the study investigator to electronically sign on their behalf. Survey is completed in same manner; electronic or via handset system built into isolation bay. Survey is conducted during inpatient admission on day 2 or whenever the patient can communicate adequately and is medically stable enough to complete a research survey. Study investigators will review patient for suitability from Day 2 of admission, on a daily basis. No long term follow-up. One time point for data collection.

No related papers found yet.